Chagas disease cardiomyopathy: Immunopathology and genetics

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Cunha Neto, Edecio ^a,b   Chevillard, Christophe ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Investigation in Immunology iii   (Brazil)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHAGAS DISEASE; DISEASE COURSE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETICS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INNATE IMMUNITY; MORTALITY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TRYPANOSOMA CRUZI; ANIMAL; CHAGAS CARDIOMYOPATHY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; CHAGAS CARDIOMYOPATHY; HUMANS;

EID: 84907257199     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/683230     Document Type: Review

References (110)

1. Salvatella R., Irabedra P., Sánchez D., Castellanos L. G., Espinal M., South-south cooperation for Chagas disease. The Lancet 2013 382 9890 395 396 10.1016/S0140-6736(13)61671-2 2-s2.0-84881132143
2. Schofield C. J., Jannin J., Salvatella R., The future of Chagas disease control. Trends in Parasitology 2006 22 12 583 588 10.1016/j.pt.2006.09.011 2-s2.0-33751234970
3. World Health Organisation, Control of Chagas Disease 2002 Geneva, Switzerland WHO World Health Organization Technical Report
4. Kirchhoff L. V., Pearson R. D., The emergence of chagas disease in the United States and Canada. Current Infectious Disease Reports 2007 9 5 347 350 10.1007/s11908-007-0053-9 2-s2.0-34548737157
5. Martín U. O., Afchain D., de Marteleur A., Ledesma O., Caprón A., Circulating immune complexes in different developmental stages of Chagas' disease. Medicina 1987 47 2 159 162 2-s2.0-0023517710
6. de Lourdes Higuchi M., de Morais C. F., Barreto A. C. P., Lopes E. A., Stolf N., Bellotti G., Pileggi F., The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clinical Cardiology 1987 10 11 665 670 10.1002/clc.4960101113 2-s2.0-0023547630
7. Bilate A. M. B., Salemi V. M. C., Ramires F. J. A., de Brito T., Silva A. M., Umezawa E. S., Mady C., Kalil J., Cunha-Neto E., The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis. Microbes and Infection 2003 5 12 1116 1124 10.1016/j.micinf.2003.07.001 2-s2.0-0141861053
8. Ramirez L. E., Lages-Silva E., Soares J. M. Jr., Chapadeiro E., The hamster (Mesocricetus auratus) as experimental model in Chagas' disease: parasitological and histopathological studies in acute and chronic phases of Trypanosoma cruzi infection. Revista da Sociedade Brasileira de Medicina Tropical 1994 27 3 163 169 2-s2.0-0028019025
9. Bestetti R. B., Muccillo G., Clinical course of chagas' heart disease: a comparison with dilated cardiomyopathy. International Journal of Cardiology 1997 60 2 187 193 10.1016/S0167-5273(97)00083-1 2-s2.0-0030738323
10. Barbosa M. M., Rocha M. O. C., Botoni F. A., Ribeiro A. L. P., Nunes M. C. P., Is atrial function in Chagas dilated cardiomyopathy more impaired than in idiopathic dilated cardiomyopathy? European Journal of Echocardiography 2011 12 9 643 647 10.1093/ejechocard/jer096 2-s2.0-84856014345
11. Milei J., Storino R., Alonso G. F., Beigelman R., Vanzulli S., Ferrans V. J., Endomyocardial biopsies in chronic chagasic cardiomyopathy. Cardiology 1992 80 5-6 424 437 10.1159/000175035 2-s2.0-0026484221
12. Cunha-Neto E., Nogueira L. G., Teixeira P. C., Ramasawmy R., Drigo S. A., Goldberg A. C., Fonseca S. G., Bilate A. M., Kalil J., Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Memorias do Instituto Oswaldo Cruz 2009 104 supplement 1 252 258 2-s2.0-68949197678
13. de Lourdes Higuchi M., Gutierrez P. S., Aiello V. D., Palomino S., Rocchi E., Kalil J., Bellotti G., Pileggi F., Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Archiv A: Pathological Anatomy and Histopathology 1993 423 3 157 160 10.1007/BF01614765 2-s2.0-0027379942
14. Reis D. D., Jones E. M., Tostes S. Jr., Lopes E. R., Gazzinelli G., Colley D. G., McCurley T. L., Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor- α + cells and dominance of granzyme A+, CD8+ lymphocytes. American Journal of Tropical Medicine and Hygiene 1993 48 5 637 644 2-s2.0-0027269642
15. Abel L. C. J., Rizzo L. V., Ianni B., Albuquerque F., Bacal F., Carrara D., Bocchi E. A., Teixeira H. C., Mady C., Kalil J., Cunha-Neto E., Chronic Chagas' disease cardiomyopathy patients display an increased IFN- γ response to Trypanosoma cruzi infection. Journal of Autoimmunity 2001 17 1 99 107 10.1006/jaut.2001.0523 2-s2.0-17844385300
16. Morato M. J. F., Colley D. G., Powell M. R., Cytokine profiles during experimental Chagas' disease. Brazilian Journal of Medical and Biological Research 1998 31 1 123 125 10.1590/S0100-879X1998000100016 2-s2.0-0031615002
17. Rocha Rodrigues D. B., dos Reis M. A., Romano A., Pereira S. A. D. L., Teixeira V. D. P. A., Tostes S. Jr., Rodrigues V. Jr., In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure. Clinical & Developmental Immunology 2012 2012 7 361730 2-s2.0-84867612465 10.1155/2012/361730
18. Añez N., Carrasco H., Parada H., Crisante G., Rojas A., Fuenmayor C., Gonzalez N., Percoco G., Borges R., Guevara P., Ramirez J. L., Myocardial parasite persistence in chronic chagasic patients. American Journal of Tropical Medicine and Hygiene 1999 60 5 726 732 2-s2.0-0344655613
19. +epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes and Infection 2005 7 4 688 697 10.1016/j.micinf.2005.01.001 2-s2.0-21144435504
20. Cunha-Neto E., Kalil J., Autoimmunity in Chagas' heart disease. São Paulo Medical Journal 1995 113 2 757 766 2-s2.0-0029258569
21. Bafica A., Santiago H. C., Goldszmid R., Ropert C., Gazzinelli R. T., Sher A., Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. Journal of Immunology 2006 177 6 3515 3519 10.4049/jimmunol.177.6.3515 2-s2.0-33748477504
22. Michailowsky V., Celes M. R. N., Marino A. P., Silva A. A., Vieira L. Q., Rossi M. A., Gazzinelli R. T., Lannes-Vieira J., Silva J. S., Intercellular adhesion molecule 1 deficiency leads to impaired recruitment of T lymphocytes and enhanced host susceptibility to infection with Trypanosoma cruzi. The Journal of Immunology 2004 173 1 463 470 10.4049/jimmunol.173.1.463 2-s2.0-2942704035
23. Bilate A. M. B., Cunha-Neto E., Chagas disease cardiomyopathy: current concepts of an old disease. Revista do Instituto de Medicina Tropical de São Paulo 2008 50 2 67 74 10.1590/S0036-46652008000200001 2-s2.0-44349123076
24. Teixeira M. M., Gazzinelli R. T., Silva J. S., Chemokines, inflammation and Trypanosoma cruzi infection. Trends in Parasitology 2002 18 6 262 265 10.1016/S1471-4922(02)02283-3 2-s2.0-0036605949
25. Marino A. P. M. P., da Silva A., dos Santos P., de Oliveira Pinto L. M., Gazzinelli R. T., Teixeira M. M., Lannes-Vieira J., Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of trypanosoma cruzi-elicited myocarditis. Circulation 2004 110 11 1443 1449 10.1161/01.CIR.0000141561.15939.EC 2-s2.0-4544384055
26. Silva J. S., Twardzik D. R., Reed S. G., Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor β (TGF- β). Journal of Experimental Medicine 1991 174 3 539 545 10.1084/jem.174.3.539 2-s2.0-0025741792
27. dos Santos R. R., Rossi M. A., Laus J. L., Silva J. S., Savino W., Mengel J., Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. Journal of Experimental Medicine 1992 175 1 29 39 10.1084/jem.175.1.29 2-s2.0-0026593438
28. Hölscher C., Mohrs M., Dai W. J., Köhler G., Ryffel B., Schaub G. A., Mossmann H., Brombacher F., Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi -infected interleukin 10-deficient mice. Infection and Immunity 2000 68 7 4075 4083 10.1128/IAI.68.7.4075-4083.2000 2-s2.0-0343081421
29. da Matta Guedes P. M., Gutierrez F. R. S., Maia F. L., Milanezi C. M., Silva G. K., Pavanelli W. R., Silva J. S., IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS neglected tropical diseases 2010 4 2 e604 10.1371/journal.pntd.0000604 2-s2.0-77950463596
30. Mariano F. S., Gutierrez F. R. S., Pavanelli W. R., Milanezi C. M., Cavassani K. A., Moreira A. P., Ferreira B. R., Cunha F. Q., Cardoso C. R., Silva J. S., The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes and Infection 2008 10 7 825 833 10.1016/j.micinf.2008.04.009 2-s2.0-45849120215
31. Moretti E., Basso B., Cervetta L., Brigada A., Barbieri G., Patterns of cytokines and soluble cellular receptors in the sera of children with acute Chagas' disease. Clinical and Diagnostic Laboratory Immunology 2002 9 6 1324 1327 10.1128/CDLI.9.6.1324-1327.2002 2-s2.0-0036842759
32. Samudio M., Montenegro-James S., de Cabral M., Martinez J., Rojas De Arias A., Woroniecky O., James M. A., Differential expression of systemic cytokine profiles in Chagas' disease is associated with endemicity of Trypanosoma cruzi infections. Acta Tropica 1998 69 2 89 97 10.1016/S0001-706X(97)00118-6 2-s2.0-0031597609
33. Ferreira R. C., Ianni B. M., Abel L. C. J., Buck P., Mady C., Kalil J., Cunha-Neto E., Increased plasma levels of tumor necrosis factor- α in asymptomatic "Indeterminate" and Chagas disease cardiomyopathy patients. Memórias do Instituto Oswaldo Cruz 2003 98 3 407 411 10.1590/S0074-02762003000300021 2-s2.0-0043239188
34. Talvani A., Rocha M. O. C., Ribeiro A. L., Correa-Oliveira R., Teixeira M. M., Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. Journal of Infectious Diseases 2004 189 2 214 220 10.1086/380803 2-s2.0-0742307348
35. Gomes J. A. S., Bahia-Oliveira L. M. G., Rocha M. O. C., Martins-Filho O. A., Gazzinelli G., Correa-Oliveira R., Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infection and Immunity 2003 71 3 1185 1193 10.1128/IAI.71.3.1185-1193.2003 2-s2.0-0037372978
36. +CD2 5high regulatory T cells in morbidity in Chagas disease. Frontiers in Bioscience 2007 12 8 2797 2806 10.2741/2273 2-s2.0-34347221200
37. da Silveira A. B. M., de Araújo F. F., Freitas M. A. R., Gomes J. A. S., Chaves A. T., de Oliveira E. C., Neto S. G., Luquetti A. O., da Cunha Souza G., Bernardino Júnior R., Fujiwara R., d'Ávila Reis D., Correa-Oliveira R., Characterization of the presence and distribution of Foxp3+ cells in chagasic patients with and without megacolon. Human Immunology 2009 70 1 65 67 10.1016/j.humimm.2008.10.015 2-s2.0-58149461555
38. Cunha-Neto E., Dzau V. J., Allen P. D., Stamatiou D., Benvenutti L., Higuchi M. L., Koyama N. S., Silva J. S., Kalil J., Liew C., Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. The American Journal of Pathology 2005 167 2 305 313 10.1016/S0002-9440(10)62976-8 2-s2.0-25144458663
39. Reis M. M., Higuchi M. D. L., Benvenuti L. A., Aiello V. D., Gutierrez P. S., Bellotti G., Pileggi F., An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: Correlation with the presence of myocardial Trypanosoma cruzi antigens. Clinical Immunology and Immunopathology 1997 83 2 165 172 10.1006/clin.1997.4335 2-s2.0-0343145700
40. Fonseca S. G., Reis M. M., Coelho V., Nogueira L. G., Monteiro S. M., Mairena E. C., Bacal F., Bocchi E., Guilherme L., Zheng X. X., Liew F. Y., Higuchi M. L., Kalil J., Cunha-Neto E., Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic chagas disease cardiomyopathy. Scandinavian Journal of Immunology 2007 66 2-3 362 371 10.1111/j.1365-3083.2007.01987.x 2-s2.0-34447319440
41. Nogueira L. G., Santos R. H. B., Ianni B. M., Fiorelli A. I., Mairena E. C., Benvenuti L. A., Frade A., Donadi E., Dias F., Saba B., Wang H. L., Fragata A., Sampaio M., Hirata M. H., Buck P., Mady C., Bocchi E. A., Stolf N. A., Kalil J., Cunha-Neto E., Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Neglected Tropical Diseases 2012 6 10 e1867 10.1371/journal.pntd.0001867 2-s2.0-84869001878
42. Munoz-Fernandez M. A., Fresno M., Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF- α and IFN- γ through a nitric oxide-dependent mechanism. Immunology Letters 1992 33 1 35 40 10.1016/0165-2478(92)90090-B 2-s2.0-0026691581
43. Araújo-Jorge T. C., Waghabi M. C., Hasslocher-Moreno A. M., Xavier S. S., Higuchi M. D. L., Keramidas M., Bailly S., Feige J., Implication of transforming growth factor- β 1 in Chagas disease myocardiopathy. Journal of Infectious Diseases 2002 186 12 1823 1828 10.1086/345882 2-s2.0-0037114922
44. Riol-Blanco L., Sánchez-Sánchez N., Torres A., Tejedor A., Narumiya S., Corbí A. L., Sánchez-Mateos P., Rodríguez-Fernández J. L., The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. The Journal of Immunology 2005 174 7 4070 4080 10.4049/jimmunol.174.7.4070 2-s2.0-15444376300
45. Liu R., Zhou C., Wang D., Ma W., Lin C., Wang Y., Liang X., Li J., Guo S., Zhang Y., Zhang S., Enhancement of DNA vaccine potency by sandwiching antigen-coding gene between secondary lymphoid tissue chemokine (SLC) and IgG Fc fragment genes. Cancer Biology and Therapy 2006 5 4 427 434 10.4161/cbt.5.4.2528 2-s2.0-33646413954
46. Teixeira P. C., Iwai L. K., Kuramoto A. C. K., Honorato R., Fiorelli A., Stolf N., Kalil J., Cunha-Neto E., Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy. Brazilian Journal of Medical and Biological Research 2006 39 12 1549 1562 10.1590/S0100-879X2006001200005 2-s2.0-33847636324
47. Teixeira P. C., Santos R. H. B., Fiorelli A. I., Bilate A. M. B., Benvenuti L. A., Stolf N. A., Kalil J., Cunha-Neto E., Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathy. PLoS Neglected Tropical Diseases 2011 5 6 e1205 10.1371/journal.pntd.0001205 2-s2.0-79959843202
48. Jiang H., Qiu G., Li-Ling J., Xin N., Sun K., Reduced ACTC1 expression might play a role in the onset of congenital heart disease by inducing cardiomyocyte apoptosis. Circulation Journal 2010 74 11 2410 2418 10.1253/circj.CJ-10-0234 2-s2.0-78349272750
49. Tostes S. Jr., Rocha-Rodrigues D. B., de Araujo Pereira G., Rodrigues V. Jr., Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. International Journal of Cardiology 2005 99 2 233 237 10.1016/j.ijcard.2004.01.026 2-s2.0-14644420959
50. Foo R. S., Mani K., Kitsis R. N., Death begets failure in the heart. The Journal of Clinical Investigation 2005 115 3 565 571 10.1172/JCI200524569 2-s2.0-14644413468
51. Zicker F., Smith P. G., Almeida Netto J. C., Oliveira R. M., Zicker E. M. S., Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy. The American Journal of Tropical Medicine and Hygiene 1990 43 5 498 505 2-s2.0-0025665195
52. Fernandez-Mestre M. T., Layrisse Z., Montagnani S., Acquatella H., Catalioti F., Matos M., Balbas O., Makhatadze N., Dominguez E., Herrera F., Madrigal A., Influence of the HLA class II polymorphism in chronic Chagas' disease. Parasite Immunology 1998 20 4 197 203 2-s2.0-15644371732
53. Deghaide N. H. S., Dantas R. O., Donadi E. A., HLA class I and II profiles of patients presenting with Chagas' disease. Digestive Diseases and Sciences 1998 43 2 246 252 10.1023/A:1018829600200 2-s2.0-0031952631
54. Layrisse Z., Fernandez M. T., Montagnani S., Matos M., Balbas O., Herrera F., Colorado I. A., Catalioti F., Acquatella H., HLA-C03 is a risk factor for cardiomyopathy in Chagas disease. Human Immunology 2000 61 9 925 929 10.1016/S0198-8859(00)00161-0 2-s2.0-0033623378
55. Colorado I. A., Acquatella H., Catalioti F., Fernandez M. T., Layrisse Z., HLA class II DRB1, DQB11, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Human Immunology 2000 61 3 320 325 10.1016/S0198-8859(99)00177-9 2-s2.0-0033999353
56. Nieto A., Beraún Y., Callado M. D., Caballero A., Alonso A., González A., Martín J., HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 2000 55 3 195 198 10.1034/j.1399-0039.2000.550301.x 2-s2.0-0034013643
57. Borrás S. G., Diez C., Cotorruelo C., Pellizon O., Biondi C., Beloscar J., Bottasso O., Racca A., HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection. Annals of Clinical Biochemistry 2006 43 3 214 216 10.1258/000456306776865205 2-s2.0-33646348988
58. Faé K. C., Drigo S. A., Cunha-Neto E., Ianni B., Mady C., Kalil J., Goldberg A. C., HLA and β -myosin heavy chain do not influence susceptibility to Chagas' disease cardiomyopathy. Microbes and Infection 2000 2 7 745 751 10.1016/S1286-4579(00)00501-3 2-s2.0-0033922971
59. Rodríguez-Pérez J. M., Cruz-Robles D., Hernández-Pacheco G., Pérez-Hernández N., Murguía L. E., Granados J., Reyes P. A., Vargas-Alarcón G., Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunology Letters 2005 98 1 97 102 10.1016/j.imlet.2004.10.017 2-s2.0-15744370951
60. Campelo V., Dantas R. O., Simões R. T., Mendes-Junior C. T., Sousa S. M. B., Simões A. L., Donadi E. A., TNF microsatellite alleles in Brazilian chagasic patients. Digestive Diseases and Sciences 2007 52 12 3334 3339 10.1007/s10620-006-9699-7 2-s2.0-35948988864
61. Beraún Y., Nieto A., Collado M. D., González A., Martín J., Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 1998 52 1 81 83 10.1111/j.1399-0039.1998.tb03028.x 2-s2.0-0031869303
62. Drigo S. A., Cunha-Neto E., Ianni B., Mady C., Faé K. C., Buck P., Kalil J., Goldberg A. C., Lack of association of tumor necrosis factor- α polymorphisms with Chagas disease in Brazilian patients. Immunology Letters 2007 108 1 109 111 10.1016/j.imlet.2006.10.008 2-s2.0-33845792965
63. Drigo S. A., Cunha-Neto E., Ianni B., Cardoso M. R. A., Braga P. E., Faé K. C., Nunes V. L., Buck P., Mady C., Kalil J., Goldberg A. C., TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes and Infection 2006 8 3 598 603 10.1016/j.micinf.2005.08.009 2-s2.0-33746292693
64. Ramasawmy R., Cunha-Neto E., Faé K. C., Müller N. G., Cavalcanti V. L., Drigo S. A., Ianni B., Mady C., Kalil J., Goldberg A. C., BAT1, a putative anti-inflammatory gene, is associated with chronic chagas cardiomyopathy. Journal of Infectious Diseases 2006 193 10 1394 1399 10.1086/503368 2-s2.0-33646350509
65. Ramasawmy R., Fae K. C., Cunha-Neto E., Müller N. G., Cavalcanti V. L., Ferreira R. C., Drigo S. A., Ianni B., Mady C., Goldberg A. C., Kalil J., Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic chagas cardiomyopathy. Journal of Infectious Diseases 2007 196 12 1836 1843 10.1086/523653 2-s2.0-39149138134
66. Pissetti C. W., de Oliveira R. F., Correia D., Nascentes G. A. N., Llaguno M. M., Rodrigues V., Association between the lymphotoxin-alpha gene polymorphism and chagasic cardiopathy. Journal of Interferon and Cytokine Research 2013 33 3 130 135 10.1089/jir.2012.0024 2-s2.0-84875015071
67. Ramasawmy R., Faé K. C., Cunha-Neto E., Borba S. C. P., Ianni B., Mady C., Goldberg A. C., Kalil J., Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among Trypanosoma cruzi-infected individuals. Molecular Immunology 2008 45 1 283 288 10.1016/j.molimm.2007.04.015 2-s2.0-34548267673
68. Costa G. C., Rocha M. O. D. C., Moreira P. R., Menezes C. A. S., Silva M. R., Gollob K. J., Dutra W. O., Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. Journal of Infectious Diseases 2009 199 3 451 454 10.1086/596061 2-s2.0-58849121536
69. Moreno M., Silva E. L., Ramírez L. E., Palacio L. G., Rivera D., Arcos-Burgos M., Chagas' disease susceptibility/resistance: linkage disequilibrium analysis suggest epistasis between major histocompatibility complex and interleukin-10. Tissue Antigens 2004 64 1 18 24 10.1111/j.1399-0039.2004.00260.x 2-s2.0-3042780037
70. Petersen C. A., Burleigh B. A., Role for interleukin-1 β in Trypanosoma cruzi-induced cardiomyocyte hypertrophy. Infection and Immunity 2003 71 8 4441 4447 10.1128/IAI.71.8.4441-4447.2003 2-s2.0-0042265159
71. Flórez O., Zafra G., Morillo C., Martín J., González C. I., Interleukin-1 gene cluster polymorphism in chagas disease in a Colombian case-control study. Human Immunology 2006 67 9 741 748 10.1016/j.humimm.2006.06.004 2-s2.0-33748928028
72. Cruz-Robles D., Chvez-Gonzlez J. P., Cavazos-Quero M. M., Prez-Mndez O., Reyes P. A., Vargas-Alarcn G., Association between IL-1B and IL-1RN gene polymorphisms and chagas' disease development susceptibility. Immunological Investigations 2009 38 3-4 231 239 10.1080/08820130902729637 2-s2.0-70350630241
73. Antúnez M. I., Cardoni R. L., IL-12 and IFN-gamma production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunology Letters 2000 71 2 103 109 10.1016/S0165-2478(99)00172-8 2-s2.0-0034142277
74. Michailowsky V., Silva N. M., Rocha C. D., Vieira L. Q., Lannes-Vieira J., Gazzinelli R. T., Pivotal role of interleukin-12 and interferon- γ axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. The American Journal of Pathology 2001 159 5 1723 1733 10.1016/S0002-9440(10)63019-2 2-s2.0-0035149345
75. Graefe S. E. B., Jacobs T., Gaworski I., Klauenberg U., Steeg C., Fleischer B., Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice. Microbes and Infection 2003 5 10 833 839 10.1016/S1286-4579(03)00176-X 2-s2.0-0041562493
76. Zafra G., Morillo C., Martín J., González A., González C. I., Polymorphism in the 3′ UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes and Infection 2007 9 9 1049 1052 10.1016/j.micinf.2007.04.010 2-s2.0-34548132097
77. O'Neill L. A. J., Bowie A. G., The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nature Reviews Immunology 2007 7 5 353 364 10.1038/nri2079 2-s2.0-34247566510
78. Ramasawmy R., Cunha-Neto E., Fae K. C., Borba S. C. P., Teixeira P. C., Ferreira S. C. P., Goldberg A. C., Lanni B., Mady C., Kalil J., Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the toll-like receptor pathway, is associated with lower risk of developing chronic chagas cardiomyopathy. Journal of Infectious Diseases 2009 199 12 1838 1845 10.1086/599212 2-s2.0-67650468816
79. Torres O. A., Calzada J. E., Beraún Y., Morillo C. A., González C. I., González A., Martín J., Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease. Human Immunology 2009 70 7 543 546 10.1016/j.humimm.2009.04.022 2-s2.0-67449149682
80. Aukrust P., Ueland T., Müller F., Andreassen A. K., Nordøy I., Aas H., Kjekshus J., Simonsen S., Frø S. S., Gullestad L., Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998 97 12 1136 1143 10.1161/01.CIR.97.12.1136 2-s2.0-0032584250
81. Talvani A., Rocha M. O. C., Barcelos L. S., Gomes Y. M., Ribeiro A. L., Teixeira M. M., Elevated concentrations of CCL2 and tumor necrosis factor- α in chagasic cardiomyopathy. Clinical Infectious Diseases 2004 38 7 943 950 10.1086/381892 2-s2.0-1842613609
82. Villalta F., Zhang Y., Bibb K. E., Kappes J. C., Lima M. F., The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infection and Immunity 1998 66 10 4690 4695 2-s2.0-0031658342
83. Machado F. S., Koyama N. S., Carregaro V., Ferreira B. R., Milanezi C. M., Teixeira M. M., Rossi M. A., Silva J. S., CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. Journal of Infectious Diseases 2005 191 4 627 636 10.1086/427515 2-s2.0-13444283754
84. Ramasawmy R., Cunha-Neto E., Faé K. C., Martello F. G., Müller N. G., Cavalcanti V. L., Iaani B., Mady C., Kalil J., Goldberg A. C., The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clinical Infectious Diseases 2006 43 3 305 311 10.1086/505395 2-s2.0-33746097383
85. Calzada J. E., Nieto A., Beraún Y., Martín J., Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001 58 3 154 158 10.1034/j.1399-0039.2001.580302.x 2-s2.0-0035174251
86. Fernández-Mestre M. T., Montagnani S., Layrisse Z., Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease? Human Immunology 2004 65 7 725 728 10.1016/j.humimm.2004.05.002 2-s2.0-4043112754
87. Dias F. C., Medina Tda S., Mendes-Junior C. T., Polymorphic sites at the immunoregulatory CTLA-4 gene are associated with chronic chagas disease and its clinical manifestations. PLoS ONE 2013 8 10 e78367 10.1371/journal.pone.0078367
88. Zafra G., Flórez O., Morillo C. A., Echeverría L. E., Martín J., González C. I., Polymorphisms of toll-like receptor 2 and 4 genes in Chagas disease. Memórias do Instituto Oswaldo Cruz 2008 103 1 27 30 10.1590/S0074-02762008000100004 2-s2.0-41149132253
89. Robledo G., González C. I., Morillo C., Martín J., González A., Association study of PTPN22 C1858T polymorphism in Trypanosoma cruzi infection. Tissue Antigens 2007 69 3 261 264 10.1111/j.1399-0039.2007.00800.x 2-s2.0-34247892256
90. Calzada J. E., Nieto A., López-Nevot M. A., Martín J., Lack of association between NRAMP1 gene polymorphisms and Trypanosoma cruzi infection. Tissue Antigens 2001 57 4 353 357 10.1034/j.1399-0039.2001.057004353.x 2-s2.0-0034993142
91. Pascuzzo-Lima C., Mendible J. C., Bonfante-Cabarcas R. A., Angiotensin-converting enzyme insertion/deletion gene polymorphism and progression of Chagas ' cardiomyopathy. Revista Espanola de Cardiologia 2009 62 3 320 322 10.1016/S0300-8932(09)70378-1 2-s2.0-63849337089
92. Calzada J. E., López-Nevot M. A., Beraún Y., Martín J., No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection. Tissue Antigens 2002 59 4 316 319 10.1034/j.1399-0039.2002.590411.x 2-s2.0-0036024129
93. Flórez O., Martín J., González Rugeles C. I., Interleukin 4, interleukin 4 receptor- α and interleukin 10 gene polymorphisms in Chagas disease. Parasite Immunology 2011 33 9 506 511 10.1111/j.1365-3024.2011.01314.x 2-s2.0-80051611759
94. Torres O. A., Calzada J. E., Beraún Y., Morillo C. A., González A., González C. I., Martín J., Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population. Infection, Genetics and Evolution 2010 10 5 682 685 10.1016/j.meegid.2010.03.009 2-s2.0-77953189157
95. Frade A. F., Pissetti C. W., Ianni B. M., Saba B., Lin-Wang H. T., Nogueira L. G., de Melo Borges A., Buck P., Dias F., Baron M., Ferreira L. R., Schmidt A., Marin-Neto J. A., Hirata M., Sampaio M., Fragata A., Pereira A. C., Donadi E., Kalil J., Rodrigues V., Cunha-Neto E., Chevillard C., Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. BMC Infectious Diseases 2013 13, article 587
96. Frade A. F., Teixeira P. C., Ianni B. M., Polymorphism in the alpha cardiac muscle actin 1 gene is associated to susceptibility to chronic inflammatory cardiomyopathy. PLoS ONE 2013 8 e83446
97. Deng X., Sabino E. C., Cunha-Neto E., Ribeiro A. L., Ianni B., Mady C., Busch M. P., Seielstad M., Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects. PLoS ONE 2013 8 e79629
98. Ishikawa T., Genetic variants in the human SLCO1B1 gene and individual variations in methotrexate clearance. Pharmacogenomics 2012 13 9 993 994
99. Ansorge H. L., Meng X., Zhang G., Veit G., Sun M., Klement J. F., Beason D. P., Soslowsky L. J., Koch M., Birk D. E., Type XIV collagen regulates fibrillogenesis: premature collagen fibril growth and tissue dysfunction in null mice. The Journal of Biological Chemistry 2009 284 13 8427 8438 10.1074/jbc.M805582200 2-s2.0-67649790258
100. Birk D. E., Fitch J. M., Babiarz J. P., Doane K. J., Linsenmayer T. F., Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. Journal of Cell Science 1990 95 part 4 649 657 2-s2.0-0025343595
101. Depre C., Hase M., Gaussin V., Zajac A., Wang L., Hittinger L., Ghaleh B., Yu X., Kudej R. K., Wagner T., Sadoshima J., Vatner S. F., H11 kinase is a novel mediator of myocardial hypertrophy in vivo. Circulation Research 2002 91 11 1007 1014 10.1161/01.RES.0000044380.54893.4B 2-s2.0-0037195691
102. Sanbe A., Marunouchi T., Abe T., Tezuka Y., Okada M., Aoki S., Tsumura H., Yamauchi J., Tanonaka K., Nishigori H., Tanoue A., Phenotype of cardiomyopathy in cardiac-specific heat shock protein B8 K141N transgenic mouse. The Journal of Biological Chemistry 2013 288 13 8910 8921 10.1074/jbc.M112.368324 2-s2.0-84875996709
103. Reis D. D., Jones E. M., Tostes S., Lopes E. R., Chapadeiro E., Gazzinelli G., Colley D. G., McCurley T. L., Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. The American Journal of Tropical Medicine and Hygiene 1993 49 2 192 200 2-s2.0-0027165447
104. Aliberti J. C., Cardoso M. A., Martins G. A., Gazzinelli R. T., Vieira L. Q., Silva J. S., Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infection and Immunity 1996 64 6 1961 1967 2-s2.0-0030010929
105. Torrico F., Heremans H., Rivera M. T., Van Marck E., Billiau A., Carlier Y., Endogenous IFN- γ is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology 1991 146 10 3626 3632 2-s2.0-0025829971
106. Gazzinelli R. T., Oswald I. P., James S. L., Sher A., IL-10 inhibits parasite killing and nitrogen oxide production by IFN- γ -activated macrophages. Journal of Immunology 1992 148 6 1792 1796 2-s2.0-0026529405
107. Müller U., Köhler G., Mossmann H., Schaub G. A., Alber G., Di Santo J. P., Brombacher F., Hölscher C., IL-12-independent IFN- γ production by T cells in experimental Chagas' disease is mediated by IL-18. Journal of Immunology 2001 167 6 3346 3353 10.4049/jimmunol.167.6.3346 2-s2.0-0035884846
108. Gomes J. A. S., Bahia-Oliveira L. M. G., Rocha M. O. C., Busek S. C. U., Tekeira M. M., Silva J. S., Correa-Oliveira R., Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infection and Immunity 2005 73 12 7960 7966 10.1128/IAI.73.12.7960-7966.2005 2-s2.0-28444480206
109. Machado F. S., Martins G. A., Aliberti J. C. S., Mestriner F. L. A. C., Cunha F. Q., Silva J. S., Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 2000 102 24 3003 3008 10.1161/01.CIR.102.24.3003 2-s2.0-0034642343
110. Guedes P. M. M., Veloso V. M., Talvani A., Diniz L. F., Caldas I. S., Do-Valle-Matta M. A., Santiago-Silva J., Chiari E., Galvão L. M. C., Silva J. S., Bahia M. T., Increased type 1 chemokine expression in experimental Chagas disease correlates with cardiac pathology in beagle dogs. Veterinary Immunology and Immunopathology 2010 138 1-2 106 113 10.1016/j.vetimm.2010.06.010 2-s2.0-77957682831